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Outcomes of an abdominal aortic aneurysm
screening program
Kevin C. Chun, BS,a Kai Y. Teng, BS,a Elyse N. Van Spyk, BS,a John G. Carson, MD,a,b and
Eugene S. Lee, MD, PhD,a,b Mather and Sacramento, Calif
Objective: In 2007, Medicare guidelines were established to identify persons at risk for the presence of an abdominal aortic
aneurysm (AAA). The purpose of this study is to evaluate the 5-year outcomes of an AAA screening program in a regional
Veterans Affairs (VA) health care system.
Methods: Data were extracted from a regional VA health care network identifying all veteran males 65 to 75 years of age
who smoked at least 100 cigarettes during their lifetime. In 2007, an AAA screening mandate was implemented allowing
patients meeting screening criteria to be evaluated for AAA as part of the patient’s health maintenance. AAA is identified
as an aortic diameter size of 3.0 cm or greater. Clinician adherence to screening protocols and referral to a vascular
surgeon for aneurysms >5.5 cm were also evaluated.
Results: A total of 9751 patients (71.5  5.6 standard deviation years of age) were screened for an AAA over a 5-year
period from January 1, 2007 to December 31, 2011. A total of 698 aneurysms (7.1%) were found. Referrals to a vascular
surgeon were made on 45 patients with aneurysms >5.5 cm. Over a 5-year period, a total of 2754 patients (28.2%) were
inappropriately screened: 416 patients were under 65 years old, 2243 patients were over 75 years old, 36 patients were
women, and 123 patients without aneurysms had multiple screenings. In 2007, during the first year of implementation,
39.2% of patients were inappropriately screened. Over the next 4 years, inappropriate screenings decreased with 33.7% in
2008, 28.6% in 2009, 17.7% in 2010, and 14.3% in 2011.
Conclusions: A large AAA screening program at the VA detects more aneurysms, but at smaller diameters than that
published in clinical trials. Over time, the number of inappropriate AAA screenings has continued to decrease,
demonstrating greater awareness and application of the AAA screening guidelines by primary care providers. Developing
surveillance guidelines for small and medium aneurysms is a potential area for future research. (J Vasc Surg 2013;57:
376-81.)
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wAbdominal aortic aneurysm (AAA) ruptures account
for 16,000 deaths each year in the United States.1 Ultra-
sonography has been proposed as a standard method of
screening for patients at risk for AAA, because ultra-
sonography is safe, easy, and effective in detecting AAA
with a sensitivity and specificity of 98% and 99%, respec-
tively.2 The United Kingdom Multicenter Aneurysm
Study (MASS) was a landmark study that evaluated the
effectiveness of a population screening program for
AAA.3 A screening program for AAA was found in the long
term to significantly reduce AAA-related mortality,4 to be
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376ore cost-effective the longer the program is implemented,
nd to demonstrate continued mortality benefit in men
ges 65 to 74 years of age.5However, debate still exists over
hether AAA screening reduces all-cause mortality.6 The
romising results in Europe were summarized by the
nited States Preventive Services Task Force (USPSTF)7
nd a Cochrane review.8 These studies conclude that AAA
creening benefits the older male population and prompted
he USPSTF to recommend screening all men 65 to 75
ears of age who have smoked 100 or more cigarettes in
heir lifetime.
In response, the U.S. Federal Government enacted
he Screen for Abdominal Aortic Aneurysms Very Effi-
iently (SAAAVE) Act into law in January 2007 as part of
he “Welcome to Medicare” package to assist clinicians
n identifying new Medicare patients at risk for AAA via
ltrasound screening. However, the law is limited to
nly new Medicare participants and does not retroac-
ively apply to current Medicare beneficiaries that meet
nclusion criteria. Selective inclusion of patients for this
creening program has led to low participation rates
ecause many physicians are required to selectively in-
lude only new patients to Medicare. Ultimately, one
illion beneficiaries were eligible for screening in 2007,
ut only 10,000 patients (less than 1% of total eligible)
ere actually screened.9 Hence, the implementation of
he 2007 SAAAVE Act was essentially ineffective and the
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Volume 57, Number 2 Chun et al 377program needed further reconsideration. Bill H.R. 1213
was introduced into Congress in 2009 to revise the
SAAAVE Act by removing the initial physical examina-
tion to encourage more new Medicare beneficiaries to
receive an ultrasound, but as of July 2012, the bill has
not been matriculated into law.10
Conversely, the Department of Veterans Affairs (VA)
mandated a national AAA screening program to imple-
ment the SAAAVE Act beginning in January 2007 that
included all eligible patients, whether new to the VA
system or already enrolled in the system, rather than
stricter Medicare guidelines. In 2008, a report done by
the VA Inspector General demonstrated that not all VA
regional health networks have an AAA screening pro-
gram, and recommended that AAA screening was feasi-
ble nationally, for which a revised national plan should
be developed.11 The VA Northern California AAA
screening program has been active since 2007, and the
long-term results of identifying patients with AAA, inap-
propriate screenings, as well as appropriate referrals to a
vascular surgeon and management strategies are un-
known. The purpose of this study is to evaluate the
5-year outcomes of an AAA screening program in a
regional VA health care system.
METHODS
A retrospective review of patient charts that were
screened for AAA was conducted under an institutional
review board approved protocol at the Veterans Affairs
Northern California Health Care System. An intent-to-
treat analysis and evaluation was made of current male
veterans, 65 to 75 years of age who smoked at least 100
cigarettes during their lifetime and females 50 years or older
with a family history of aneurysmal disease. Patients that
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Fig 1. Graph of the mean age of all total screened and a
(AAA) over a 5-year span. The mean age of patients screen
in 2007 is significantly older than screened patients in 20
(P  .001).met inclusion criteria were sent notices from the radiology cepartment to participate in the AAA screening. In addi-
ion, alerts in the patient’s electronic medical record called
omputerized Patient Record System (CPRS), notified
rimary care physicians when eligible patients were due for
AA screening.
A billing code was developed for tracking AAA screen-
ng utilization when the AAA screening program began.
his code was entered after a patient completed a screening
ltrasound for AAA by radiology. A list was generated using
his code of all patients that were screened from January 1,
007 to December 31, 2011. Decision Support System
DSS) was the program used for tracking AAA screening
osts. The use of DSS by the Department of Veterans
ffairs in tracking health care cost information has been
escribed elsewhere.12,13
Age, maximum aortic diameter, AAA prevalence, and
linical adherence of the screening program were evalu-
ted. An aneurysm was defined as having a maximum
bdominal aortic diameter of 3.0 cm or greater. The
adiologist at the time of ultrasound verified the mea-
urements of the aorta and reported these findings in
PRS. Aneurysm prevalence was compared with the
ASS study, a major data source for the USPSTF rec-
mmendations. Clinical adherence was measured by the
ncidence of inappropriate screenings and referrals made
o a vascular surgeon for aneurysms detected that were
.5 cm or greater. An inappropriate screening is defined
s a patient screening that did not meet USPSTF AAA
creening criteria.
The continuous variables are reported as mean 
tandard deviation. A two-tailed t-test was used to com-
are continuous variables and a 2 test was used to
ompare data proportions. A P value of less than .05 was
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A total of 9751 patients (71.5 5.6 years of age) were
screened for AAA from January 1, 2007 to December 31,
2011 at the VA Northern California Health Care System.
Over the course of 5 years, 2779 patients were screened in
2007, 1786 patients in 2008, 1837 patients in 2009, 1739
patients in 2010, and 1610 patients in 2011. The average
age of patients screened steadily declined over the 5-year
time period: 73.8  4.1 years in 2007, 72.5  5.9 years in
2008, 71.5 5.9 years in 2009, 69.7 5.1 years in 2010,
and 68.1  4.9 years in 2011 (Fig 1). These numbers
included inappropriately screened patients that did not fit
screening criteria. The total patients screened in 2007 were
significantly older than the total patients screened in 2011
(P  .001). When removing these inappropriate screens,
the average age of appropriately screened patients (n 
6997) also steadily declined over the 5-year period (Fig 1).
The appropriately screened patients in 2007 were signifi-
cantly older than in 2011 (P .001). All screened patients
were 99.6% men (9715/9751). The ethnicities consisted
of 60.1% (5860/9751) White, 10.5% (1024/9751)
Black/African American, 3.5% (341/9751) Asian or Pa-
cific Islander, 0.8% (78/9751) American Indian, and
25.1% (2448/9751) with an unknown ethnicity. A total of
513 (513/9751, 5.3%) patients died during the 5-year
period.
A total of 698 aneurysms (698/9751, 7.2%) were
detected in the screening program (Table I). Overall, more
aneurysms were found in this study than the MASS study.
There were more small aneurysms (3.0-4.4 cm) detected in
the current study compared with small aneurysms in the
MASS study (77.9% vs 71%; P .001). However, the large
aneurysm group (5.5 cm) in this study was significantly
smaller than the large aneurysm group in the MASS study
(6.6% vs 12%; P .001). The current study also detected a
higher percentage of total aneurysms (7.2% vs 4.9%; P 
.001) and inconclusive results (1.7% vs 1.2%; P  .001)
than in theMASS study. Ultrasound studies deemed incon-
clusive meant that there was no discernible image for the
radiologist to accurately measure the maximum aortic di-
ameter. A total of 85 patients with AAA (12.2% of detected
aneurysms) died during the 5-year period. One aneurysm-
related death was reported. A patient died from AAA
rupture before a scheduled elective AAA repair. Out of the
698 patients with detected aneurysms, 302 patients did not
fit inclusion criteria for screening. There were 238 patients
(34.1% of detected aneurysms) with small or medium an-
eurysms (3.0-5.4 cm) that had no further diagnostic imag-
Table I. Aneurysms detected with AAA screening
Study Inconclusive Total an
5-year VA study (n  9751) 169 (1.7%) 698
MASS study (n  27,147) 329 (1.2%) 1333
P value P  .001 P 
AAA, Abdominal aortic aneurysm; VA, Veterans Affairs.ing for surveillance. oThere were 46 patients in the large aneurysm group
5.5 cm) out of the 698 patients with detected aneurysms
Table II). Forty-five patients were referred to the vascular
urgery clinic. The one patient not referred ultimately
efused vascular surgery consultation. The clinical adher-
nce for vascular surgery referral upon large aneurysm
etection is 97.8%. There were 31 patients (67.4% of large
neurysm group) that received elective surgical AAA repair.
ut of these 31 patients, eight opted to have surgical repair
t a non-VA medical facility. There were 12 patients that
ied in the large aneurysm group, and as previously stated,
ne patient was reported to have died from rupture.
A total of 2754 patients (2754/9751, 28.2%) were
nappropriately screened. There were 2243 patients that
ere over 75 years of age, 416 patients that were younger
han 65 years of age, and 36 women were screened without
family history of aneurysmal disease. The overall percent-
ges of inappropriate screens per year are as follows: 39.2%
1089/2779) in 2007, 33.7% (602/1786) in 2008, 28.6%
525/1837) in 2009, 17.7% (308/1739) in 2010, and
4.3% (230/1610) in 2011. Inappropriate screens of
9.2% (1089/2779) in 2007, from the first year of the
rogram, significantly decreased to 14.3% (230/1610) in
011 (P .001) (Fig 2). The clinical adherence on screen-
ng all eligible patients was 71.8%. A total of 123 patients
1.3% of total patients) with a normal aorta had multiple
creenings. The 169 patients (1.7%) with inconclusive re-
ults received no further diagnostic imaging to identify the
resence of an AAA.
Based on the DSS cost analysis, the cost per ultrasound
or AAA screening was $41.38 as of March 2012. The cost
as derived from the actual costs of running the radiology
epartment divided by the proportion of costs allocated to
unning the AAA screening program. The AAA screening
rogram is a noncount clinic; there is nomaximum number
ms 3.0-4.4 cm 4.5-5.4 cm 5.5 cm
) 544 (77.9%) 108 (15.5%) 45 (6.6%)
) 944 (71%) 223 (17%) 166 (12%)
P  .001 P  .47 P  .001
able II. Summary of large aneurysm group (n  46)
verage AAA diameter 6.6  1.1 cm
atients referred to vascular surgeon after
detection 45 (97.8%)
atients received elective repair 31 (67.4%)
atients received elective repair at VA 23 (50%)
atients received elective repair at non-VA
facility 8 (17.4%)
atients died within 5-year period 12 (26.1%)
atients died from AAA rupture 1 (2.2%)
AA, Abdominal aortic aneurysm; VA, Veterans Affairs.eurys
(7.2%
(4.9%
.001f patients to be seen in a given day for an ultrasound
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Volume 57, Number 2 Chun et al 379appointment for AAA screening. Equipment costs such as
ultrasound machines, gurneys, and probes were not in-
cluded in the overall cost estimate because the VA already
owns the capital equipment. The VA Northern California
Health Care Systemmedical centers that participated in the
AAA screening program were Sacramento (Mather, Calif),
Martinez, Oakland, Chico, and Redding.
DISCUSSION
This is the first study to date evaluating the long-term
outcomes of an AAA screening program in clinical practice
from the implementation of the SAAAVE Act. The VA
Northern California Health Care System has made a strong
effort to implement the SAAAVE Act to improve the
quality of health care to its veterans by allowing as many
eligible patients as possible to participate in the AAA
screening program. The VA Northern California AAA
screening program continues to run today.
TheMASS study was used as a hypothetical benchmark
for comparing the results of detected aneurysms vs this
study based upon recommendations made by theUSPSTF7
and a Cochrane review.8 The application of any random-
ized prospective clinical trial would have its associated
limitations, such as recruiting patients outside an organized
health care system. Additionally, knowledgeable health care
providers dedicated to AAA screening would yield different
results. We endeavor to compare our results of implement-
ing the screening study to theMASS study. Compared with
this study, the MASS study had fewer detected aneurysms,
fewer inappropriate screenings, fewer inconclusive results,
and more large aneurysms at the time of patient diagnosis.
These differences may be due to the rigorous nature of a
prospective study and the inclusion of a general at-risk
population. Eligible veterans utilizing their health care
benefits at the VA may therefore lead to earlier AAA detec-
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Fig 2. The number of inappropriate screenings over a
decreases over time. The percentages of inappropriate s
2009, 17.7% in 2010, and 14.3% in 2011. In 2007, the p
in 2011 (P  .001).tion and a narrower distribution of AAAs detected in the iASS study. We propose that the implementation of a
creening protocol in clinical practice may be closer in line
ith our aneurysm detection rates, inappropriate screen-
ngs, and diameter distribution given that the screening
rogram will be in the context of an organized health care
ystem.
In contrast, the MASS study detected a higher percent-
ge of large aneurysms (5.5 cm)3 than this study. Large
neurysms are considered high-risk for rupture, and referral
o a vascular surgeon upon aneurysm detection is essential
or reducing aneurysm-related death. Upon detection, the
ypical AAA diameter for elective repair is 5.5 cm or
reater.6 Veterans that utilize their health care benefits may
ave better risk factor management, or yet, better access to
ascular specialists than their European counterparts. This
ay reflect the lower incidence of large aneurysms in this
tudy compared with the MASS study.
There were a fair number of detected aneurysms in
atients (n  238, 34.1% of all aneurysms) that did not
eceive follow-up imaging studies. In a subanalysis of this
roup, there were 26 patients that died with no reported
neurysm-related cause of death. We speculate that a vari-
ty of factors play a role for these patients in not receiving
ollow-up ultrasound studies. Some of these include patient
o-shows to vascular appointments, AAA screening clinic
ancelations, a lack of awareness of current AAA surveil-
ance protocols by primary care physicians, or that the
atient decided to follow-up at another non-VA medical
acility. These patients, as well as in other AAA screening
rograms, are ideal for future prospective studies on AAA
xpansion rates and whether or not they are at high-risk for
upture.
The number of inappropriate screenings is a good
ndicator of how well primary care providers are familiar
ith screening criteria. Over the 5-year period, 28.2%
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possible, particularly in the first year. The first year the
program went into effect, 39.2% of the patients screened
did not fit inclusion criteria; a large portion of the total
number of patients in 2007. Physicians in the VA are
rewarded formeeting clinical reminders, but not necessarily
punished for ordering inappropriate diagnostic tests. For
instance, 123 patients screened in this study with a normal
aorta hadmultiple screenings.Multiple unnecessary screen-
ings lead to wasted time and effort of the patient and their
health provider. The overall percentage of inappropriate
screens improved over the ensuing years and by 2011,
inappropriate screenings were 14.3%.
The 302 aneurysms detected in the inappropriately
screened patients were unexpected. We conducted a sub-
analysis on the 302 patients with AAA that did not fit
screening criteria. Out of the 302 inappropriately screened
patients with AAA, 55 patients were younger than 65 years
of age, 244 patients were older than 75 years of age, and 3
women were screened with no family history of aneurysmal
disease. There were 18 patients with a large AAA (5.5 cm)
out of the 302 patients. Although these patients are new to
the VA, we suspect these patients were not at the VA for
AAA screening, but for follow-up studies for their current
AAA. Therefore, the 302 patients with AAA that did not
meet screening criteria were inappropriately coded for
screening, not inappropriately screened, by primary care
providers and radiologists. This coding error becomes a
major limitation of the retrospective review analysis of this
AAA screening program in a large organized health care
system.
The reduction of inappropriate screenings over the
years signifies an improvement of the screening program’s
clinical adherence and understanding of AAA screening
guidelines. We suspect that VA primary care providers were
approached over the years by quality assurance and patient
care administrators, as well as vascular surgeons on remind-
ing them to order abdominal ultrasound studies based on
USPFTF guidelines. Regular AAA screening clinical re-
minders in the electronic medical record also reduce the
incidence of inappropriate screens. Using these measures,
other organized non-VA health systems with an electronic
medical record, such as Kaiser, can adopt an AAA screening
program similar to the VA.
The average ageof screened individuals shoulddecrease as
the AAA screening program matures because newer eligible
patients would be screened closer to the minimum age, since
the older eligible patients within the population were already
targeted. In a subanalysis, we removed the patients with
inappropriate screens in determining a more accurate as-
sessment of declining average ages of screened patients.
The appropriately screened patients were in fact declining
over the 5-year period. Given the declining age for the
initial screening for patients at risk for AAA, we would
expect a decrease in the identification of large AAA.7
Another limitation to this study is that the SAAAVE
Act is not a randomized controlled trial and does not
account for the patients who were not screened. The atten- cance rate, one measure of clinical adherence, has been
ore difficult to track over a longer time period because
any eligible patients were invited several times or may
ave simply been referred for AAA screening by their
rimary care provider when the patients were in the clinic
acility. Therefore, we cannot accurately count the number
f invitations actually sent to all eligible patients within the
-year period to obtain an attendance rate. However, given
hat the current Veteran population is more homogenous
or being at-risk for AAA than a non-VA population, and
hat more aneurysms were detected than in the MASS
tudy, we suspect that the attendance rate for AAA screen-
ng in this study is higher than in the MASS study. A more
vidence-based approach to tracking these patients is war-
anted.
In 2008, the VA Northern California reported to have
ost $53 per AAA ultrasound.14 The $41 per AAA ultra-
ound in 2012 would translate into $38 in 2008 dollars
ccording to the July 2012 U.S. Consumer Price Index,
eaning that we speculate the long-term implementation
f the current screening program is cost-effective. How-
ver, obtaining a more precise cost measurement would
equire actual attendance rates, which we deemed difficult
o accurately measure. The cost per ultrasound should
ecrease by limiting the number of inappropriate screen-
ngs and increasing AAA screening participation of new,
ligible patients.
Once an AAA is detected, the typical life expectancy of
patient is around 11 years.4 Given the potential long life
xpectancy, the patient may undergo multiple imaging
tudies, which add to health care costs, thereby decreasing
he cost-effectiveness of the screenings. Surveillance with
dditional ultrasound examinations is recommended for
atients with a detected AAA15 but uncertainty exists over
pproximate time intervals.6,15-18 A reason for this uncer-
ainty could be a lack of understanding on the expansion
ates of aneurysms. There is consensus among the studies
hat the expansion rate for small aneurysms is slow, but the
ate varies in speed depending on the AAA diame-
er.15,16,18 Primary care providers may unintentionally or-
er too many follow-up ultrasound studies than necessary.
e suspect that small and medium-sized aneurysms are
maged much more frequently than necessary in AAA
creening programs. Evidence to evaluate this would be
aluable information, as well as determining overall costs of
epeat studies with risks vs benefits.
Other benefits may arise from an active screening pro-
ram. For example, an ectatic aorta detected from an
ltrasound may also signify increased cardiovascular disease
isk.19 Collecting data on risk factors such as hypertension,
iabetes, smoking status, cardiovascular disease, body mass
ndex, renal function, statin use, and endothelial barrier
ysfunction may give better insight to AAA pathophysiol-
gy. A more concrete understanding of AAA formation
ay lead to better treatments and patient care upon detec-
ion of an ectatic aorta or aneurysm, especially on aortic
iameters that measure closer to 3.0 cm.More importantly,
linicians can target the most at-risk group of patients to
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Volume 57, Number 2 Chun et al 381screen for AAA. Future studies on determining which
factors influence AAA pathophysiology and expansion rates
are of importance. These may include clinical trials on using
the pleiotropic effects of statins to decrease AAA expansion
rates,15 pluripotent stem cells20 and endothelial progenitor
cells21 on repairing aortic tissue breakdown, and the inhi-
bition of endothelial nitric oxide synthase uncoupling to
prevent AAA development.22
In conclusion, a large AAA screening program at the
VA detects more aneurysms, but at smaller diameters than
those published in clinical trials. Over time, the number of
inappropriate AAA screenings has continued to decrease,
demonstrating greater awareness and application of the
AAA screening guidelines by primary care providers. De-
veloping surveillance guidelines for small and medium an-
eurysms is a potential area for future research.
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